Reston, VA, March 3, 2018 – Brillient Corporation announced today that the Food and Drug Administration (FDA) has awarded the company a single award Blanket Purchase Agreement (BPA) with a five-year performance period (including options) and a ceiling of $49 million to provide professional and technical services. As FDA undertakes new scientific and consumer safety initiatives, the Brillient team will provide expertise in the areas of program evaluation, policy development, strategic communications, budget/financial management, as well as overarching program and project management support. Brillient will deliver solutions and technical/scientific resources to meet the needs of program offices and centers across all of FDA.
“We are honored to have been selected to support the FDA’s critical mission of protecting and advancing public health. Brillient is excited to add the FDA as a client and shares their focus on innovation and information management. We look forward to a productive partnership with FDA and exceeding expectations” stated Sukumar Iyer, Brillient’s Chief Executive Officer.
About Brillient: Brillient is a fast-growing solutions engineering company with 11 years of experience providing information management, intelligent solutions and business process management services. Brillient has supported 16 federal government clients and employs more than 450 personnel in 11 states. The company was recognized as the 2017 DHS Small Business of the Year and maintains ISO 9001:2015, ISO 20000-1:2011, ISO 27001:2013, and SEI CMMI Level 3 quality certifications. In the health sector, in addition to this contract at FDA, Brillient is also a prime contractor on the Centers for Medicare and Medicaid (CMS) SPARC vehicle. To learn more about our company, please visit www.brillient.net.
703 994 4232